Skip to main content
Clenbuterol Therapy for Amyotrophic Lateral Sclerosis

Clenbuterol Therapy for Amyotrophic Lateral Sclerosis

Unmet Need Amyotrophic lateral sclerosis (ALS) is a debilitating disease with progressive loss of muscle function and inevitable death usually in 3-5 years. There are currently two available therapies on the market which prolong life…

Read More

An implanted biomaterial to accelerate bone healing

An implanted biomaterial to accelerate bone healing

Unmet Need A leading concept in regenerative medicine is transplantation of tissue-specific cells, often supported with biomaterials, to promote tissue repair. While this strategy has achieved some success, its broad clinical application is hindered by…

Read More

A therapeutic formulation for preventing posttraumatic osteoarthritis after joint injuries

A therapeutic formulation for preventing posttraumatic osteoarthritis after joint injuries

Value Proposition Osteoarthritis (OA) is an affliction of the joints that affects approximately 27 million people in the U.S . Posttraumatic osteoarthritis (PTOA), or osteoarthritis occuring after joint injury, accounts for approximately 12% of these…

Read More

Novel dystonia treatment drugs

Novel dystonia treatment drugs

Value Proposition Dystonia is a movement disorder characterized by sustained, often painful involuntary postures, causing motor disabilities and a marked decrease in quality of life. Dystonia is the third most common movement disorder behind Parkinson’s…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us